Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kurt Stenmark to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Kurt Stenmark has written about Dose-Response Relationship, Drug.

 
Connection Strength
 
 
 
0.033
 
  1. Qian J, Tian W, Jiang X, Tamosiuniene R, Sung YK, Shuffle EM, Tu AB, Valenzuela A, Jiang S, Zamanian RT, Fiorentino DF, Voelkel NF, Peters-Golden M, Stenmark KR, Chung L, Rabinovitch M, Nicolls MR. Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension. Hypertension. 2015 Dec; 66(6):1227-1239.
    View in: PubMed
    Score: 0.023
  2. Dempsey EC, Stenmark KR, McMurtry IF, O'Brien RF, Voelkel NF, Badesch DB. Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J Cell Physiol. 1990 Jul; 144(1):159-65.
    View in: PubMed
    Score: 0.004
  3. Burghuber OC, Morganroth ML, Stenmark KR, Morris KG, Reeves JT, Voelkel NF. [Inhibition of hypoxic pulmonary vasoconstriction by leukotriene blockade]. Wien Klin Wochenschr. 1986 Feb 21; 98(4):113-7.
    View in: PubMed
    Score: 0.003
  4. Sugita T, Stenmark KR, Wagner WW, Henson PM, Henson JE, Hyers TM, Reeves JT. Abnormal alveolar cells in monocrotaline induced pulmonary hypertension. Exp Lung Res. 1983 Nov; 5(3):201-15.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)